Please login to the form below

Not currently logged in
Email:
Password:

Parexel appoints CEO

Jamie Macdonald succeeds co-founder Josef von Rickenbach

Jamie MacdonaldBiopharmaceutical services provider, Parexel, has appointed Jamie Macdonald as its chief executive officer (CEO), a role that will see him succeed Josef von Rickenbach.

Macdonald previously led INC Research, now known as Syneos Health, for several years first as CEO and most recently as vice chairman.

He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.

Macdonald said: “As a trail blazer in the biopharmaceutical services industry, the company enjoys well-deserved recognition as having the kind of deep therapeutic and functional expertise, global reach and innovative capability to continue its leadership.

“I am humbled to have the opportunity to build on this legacy and look forward to continued growth and excellence for Parexel.”

20th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics